课题基金 / 基金详情

Function of the protein EFF-1 in cell membrane fusion

Function of the protein EFF-1 in cell membrane fusion
蛋白质EFF-1在细胞膜融合中的功能
批准号:
6841163
负责人:
WILLIAM A MOHLER
金额:
$28.88万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2007-12-31

项目摘要

项目成果

WILLIAM A MOHLER的其他基金

相似基金

相关文献

中文摘要
翻译
超出所提供的空间。这项建议的长期目标是了解细胞膜在正常动物发育中成为融合能力的机制。体细胞融合形成合胞体组织是人类发育的重要组成部分,细胞融合是一个古老的过程,在所有真核生物门的进化中共享。然而,在所有物种中,细胞融合的分子机制基本上是未知的。因此,寻找驱动质膜融合的分子是了解人类健康的主要优先事项。我们对秀丽隐杆线虫的研究发现了ef -1,这是已知的所有物种中第一个完全需要并且完全特定于细胞膜融合过程的细胞膜蛋白。ef -1是一种新型的I型膜蛋白,其序列基序提示其通过直接相互作用和/或膜脂加工的作用模式:磷脂酶A2活性位点和潜在的病毒样两亲性融合肽。突变细胞中功能性ef -1的缺失阻碍了细胞膜融合过程的早期阶段。我们建议确定ef -1在膜融合中的分子功能,并通过以下探究线进一步剖析细胞融合的完整机制:1。通过定向突变分析和酶活性测定,绘制和测试ef -1的功能域。2. 通过在活胚胎的融合细胞中标记的EFF-1蛋白成像,评估EFF-1在细胞融合事件的动态结构背景下的作用。3. 通过分离与ef -1在物理和遗传上相互作用的分子,鉴定细胞融合机制的其他蛋白质成分。该提案是为了响应NICHD的PAS-00-067:“膜特性:精子/微生物敏感性的探索”而提交的,因为它专注于PA专门针对的主题。然而,拟议研究的科学影响具有普遍意义。我们的研究结果将增加对发育细胞融合的分子机制的理解,这是动物繁殖、发育和健康的一个关键和未被探索的组成部分。网站性能 ======================================== 节结束 ===========================================
英文摘要
EXCEED THE SPACE PROVIDED. The long-term goal of this proposal is to understand the mechanisms by which cell membranes become fusion competent in normal animal development. The fusion of somatic cells to form syncytial tissues is an essential part of human development, and cell fusion is an ancient process, shared in evolution by all eukaryotic phyla. Yet the molecular mechanism of cell fusion is essentially unknown in all species. Finding the molecules that drive plasma membrane fusion is therefore a major priority in understanding human health. Our studies of the nematode C. elegans have uncovered EFF-1, the first cellular membrane protein in any species that is known to be completely required for and completely specific to the process of cell membrane fusion. EFF-1 is a novel type I membrane protein, with sequence motifs that suggest modes of action via direct interaction and/or processing of membrane lipids: a phospholipase A2 active site, and a potential virus-like amphipathic fusion peptide. The absence of functional EFF-1 in mutant cells blocks cell membrane fusion at the earliest step in the process. We propose to determine the molecular function of EFF-1 in membrane fusion, and to further dissect the full mechanism of cell fusion via the following lines of inquiry: 1. Map and test the functional domains of EFF-1 through directed mutation analysis and via assays of enzymatic activity. 2. Assess the role of EFF-1 within the dynamic structural context of a cell fusion event by imaging of labeled EFF-1 protein within the fusing cells of live embryos. 3. Identify other protein components of the cell fusion machinery through isolation of molecules that interact physically and genetically with EFF-1. This proposal is submitted in response to PAS-00-067 from NICHD: "Membrane properties: Exploration of sperm/microbe susceptibility", as it focuses on topics specifically targeted by the PA. The scientific impact of the proposed research is of general import, however. Our results will increase understanding of the molecular mechanism underlying developmental cell fusion, a crucial and under-explored component of animal reproduction, development, and health. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2009 Cell-Cell Fusion
  • 批准号:
    7667076
  • 项目类别:
  • 资助金额:
    $0.9万
  • 财政年份:
    2009
  • 负责人:
    WILLIAM A MOHLER
  • 依托单位:
Spinning Microlens Confocal Microscope
SPINNING MICROLENS CONFOCAL MICROSCOPE: CELL & MOLECULARBIOLOGY: PROTEIN
Function of the protein EFF-1 in cell membrane fusion
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: